Artificial Intelligence for Rare Disease Diagnosis
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorPeking Union Medical College Hospital
About this trial
A multicentre, randomised diagnostic accuracy study to evaluate whether the rare disease-specific AI can improve diagnostic accuracy and efficiency for physicians managing real-world clinical cases.
Eligibility criteria
Qualifiers
1. Licensed physicians at the junior or senior level affiliated with internal medicine, neurology, pediatrics, and rare disease-related departments.
2. Willingness to provide written informed consent, adhere to trial protocols, and complete all required pre-study training prior to enrollment.
Disqualifiers
1. Prior exposure to any of the clinical cases included in the study case library.
2. Direct participation in the design or development of the AI model.
Trial design
Treatments tested in this trial
- AI-Assisted Diagnosis
Treatment groups
150 Participants
are divided into 2 treatment groupsSponsors and collaborators
Peking Union Medical College Hospital
Lead sponsor
Cangzhou Central Hospital
Collaborator
Zhangzhou Municipal Hospital of Fujian Province
Collaborator
Dongguan People's Hospital
Collaborator
First People's Hospital of Foshan
Collaborator
Tibet Autonomous Region People's Hospital
Collaborator
Guizhou Provincial People's Hospital
Collaborator
Tianjin Children's Hospital
Collaborator
The First People's Hospital of Yunnan
Collaborator
Qinghai People's Hospital
Collaborator
Source ClinicalTrials.gov